Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
EYPT — EyePoint Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 4, 2026
REVENUE
$620000 -35.8%
NET MARGIN
-10904.7% -4721.2 PTS
EPS
-$0.81 +4.7%
FREE CASH FLOW
-$66.0M -9.8%

No summary has been written for this call yet.